North American Transcranial Dopplers (TCD) Market
- Report Code: TR 1001
- Publish Date: Upcoming
Transcranial doppler (TCD) refers to a non-invasive ultrasound method, which is used to examine the circulation of blood in a person’s brain. TCD ultrasound can also be used to monitor the blood flow in brain, especially during surgery. This kind of ultrasound technique is utilized for patients suffering from stroke. The high incidence of brain disorders and stroke in the North American region is one of the most important reasons driving factors of this market.
The North American market accounted for a 12.62% share of the global transcranial doppler market in 2013. It is the second-largest market as compared to other regions. The North American market segment is projected to grow at a CAGR of 4.9%, from 2013 to 2018. Emboli detection, sickle cell disease, and intracranial stenosis are among the major application segments of the TCD market in North America. Healthcare expenditure is also an essential macroeconomic factor that impacts the growth of the TCD market.
Research statistics have suggested that over one-fifth of the population in the U.S. suffers from brain/mental disorders. This increasing prevalence of brain disorders has created a huge demand for more investments in the brain monitoring devices sector, with special focus on the transcranial doppler market segment. These factors are expected to drive the growth of the North American TCD market. Some of the major companies that have contributed towards the growth of this market include Integra LifeSciences (U.S.), Cadwell Laboratories, Inc. (U.S.), and Natus Medical, Inc. (U.S.) among others.
The North American transcranial doppler market report offers a comprehensive overview on the current market trends and market dynamics encompassing drivers, restraints, and upcoming opportunities. It also lays emphasis on market sizing and forecast of market revenue. This report presents a competitive landscape of key players thriving in this market, along with their market share, recent developments, and growth strategies adopted by them. The North American transcranial doppler market is classified on the basis of geography and application. The U.S., Canada, and Mexico are the countries that have been considered for this extensive market analysis. On the basis of applications, the market has been segmented into emboli detection, intracranial stenosis, sickle cell disease, and subarachnoid hemorrhage.
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Brain Monitoring Devices The North American Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders which was valued at $1119.6 million in 2012 and is poised to grow at a CAGR of 9.0% to reach $1834.0 million by 2018. North American Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The major players extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
European Brain Monitoring Devices The European Brain monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The European Brain monitoring market was valued at $279.9 million in 2012 and is poised to grow at a CAGR of 8.6% to reach $458.5 million by 2018. The European Brain monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
Asian Brain Monitoring Devices The Asian Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The Asian brain monitoring market was valued at $162.3 million in 2012 and is poised to grow at a CAGR of 9.2% to reach $275.1 million by 2018. The Asian Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in the Asian brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
